BANGALORE (Reuters) – The U.S. Food and Drug Administration (FDA) said it is reviewing results from two studies that showed there is a higher risk of blood clots in women taking birth control pills containing drospirenone.
The FDA said it is evaluating the conflicting results from these and earlier studies and reviewing the risks and benefits of drospirenone-containing birth control pills.
Bayer AG’s best-selling birth control drugs, including Yaz and Yasmin, contain the compound.
The two studies looked at whether there is a higher risk of blood clots in women taking birth control pills containing drospirenone, when compared to similar women taking pills containing levonorgestrel.
The studies showed the risk of blood clots is reported to be up to 2 to 3 times greater than with levonorgestrel-containing pills.
As technology advances, more and more medical procedures are able to be performed in a…
Women often prefer their OBGYN over their regular doctor for many procedures, but may wonder…
Gynecological Problems The female body is unique, sensitive, strong, and complex. For a woman to…
If you suffer from urinary incontinence, then you're no stranger to the frustrating problem of…
Obstetrician At Fleur Women's Health in Rancho Mirage, CA, we are obstetrics professionals. Our team…
Being sexually active means making responsible choices about every aspect of your sexual and reproductive…